Management ChangeJun 8, 2026, 05:06 PM
Mira Pharmaceuticals Appoints Andriy Mushak as Fractional CFO
AI Summary
Mira Pharmaceuticals, Inc. announced the departure of Alan Weichselbaum as Chief Financial Officer, effective June 6, 2026. His departure was not due to any disagreement with the company. Concurrently, the board appointed Andriy Mushak as the company's fractional Chief Financial Officer, effective June 6, 2026. Mr. Mushak, a CPA with over 20 years of experience, will provide services through LMAM Consulting Group, LLC for $6,000 per month.
Key Highlights
- Alan Weichselbaum ceased serving as CFO of Mira Pharmaceuticals effective June 6, 2026.
- His departure was not due to any disagreement with the company.
- Andriy Mushak was appointed as the fractional Chief Financial Officer, effective June 6, 2026.
- Mr. Mushak is a CPA and Partner at LMAM Consulting Group, LLC, with over 20 years of experience.
- He will provide services through LMAM Consulting Group for $6,000 per month.
Price Impact
More from MIRA